Positive results of progeria treatment were obtained for the first time
Lonafarnib is a drug for the treatment of cancer, improved the condition of children with progeria. The study of its and other farnesyltransferase inhibitors will help to better understand the causes of diseases of the cardiovascular system and the mechanisms of normal aging.
27.09.2012